ABCL – AbCellera Biologics Inc.

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ABCL #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

ABCL — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

21.68

Margin Of Safety %

Put/Call OI Ratio

0.17

EPS Next Q Diff

-0.17

EPS Last/This Y

-0.21

EPS This/Next Y

-0.07

Price

3.31

Target Price

9.2

Analyst Recom

1.29

Performance Q

-3.79

Upside

-293.0%

Beta

0.94

Ticker: ABCL

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	ABCL	3.53	0.17	1.02	82456
2026-03-10	ABCL	3.59	0.17	0.04	82381
2026-03-11	ABCL	3.65	0.17	1.58	82956
2026-03-12	ABCL	3.47	0.18	1.05	83660
2026-03-13	ABCL	3.47	0.18	1.05	83660
2026-03-17	ABCL	3.56	0.18	0.03	84413
2026-03-18	ABCL	3.53	0.18	0.44	84474
2026-03-19	ABCL	3.52	0.18	0.39	84876
2026-03-20	ABCL	3.4	0.18	0.11	84992
2026-03-23	ABCL	3.37	0.17	0.18	77755
2026-03-24	ABCL	3.31	0.17	0.03	77635
2026-03-25	ABCL	3.38	0.18	0.28	77737
2026-03-26	ABCL	3.35	0.18	0.83	78254
2026-03-27	ABCL	3.28	0.18	0.50	78343
2026-03-30	ABCL	3.29	0.18	0.18	78363
2026-03-31	ABCL	3.49	0.17	0.70	79207
2026-04-01	ABCL	3.52	0.17	0.10	80045
2026-04-02	ABCL	3.52	0.17	0.16	80248
2026-04-06	ABCL	3.39	0.17	0.74	80595
2026-04-07	ABCL	3.3	0.17	8.27	80932
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	ABCL	3.53	-33.3	-	-0.70
2026-03-10	ABCL	3.59	-33.3	-	-0.70
2026-03-11	ABCL	3.64	-33.3	-	-0.70
2026-03-12	ABCL	3.47	-33.3	-	-0.70
2026-03-13	ABCL	3.49	-33.3	-	-0.70
2026-03-17	ABCL	3.56	-33.3	-	-0.70
2026-03-18	ABCL	3.52	-33.3	-	-0.70
2026-03-19	ABCL	3.53	-33.3	-	-0.70
2026-03-20	ABCL	3.40	-33.3	-	-0.70
2026-03-23	ABCL	3.37	-33.3	-	-0.70
2026-03-24	ABCL	3.31	-33.3	-	-0.70
2026-03-25	ABCL	3.38	-33.3	-	-0.70
2026-03-26	ABCL	3.35	-33.3	-	-0.70
2026-03-27	ABCL	3.28	-33.3	-	-0.70
2026-03-30	ABCL	3.29	-33.3	-	-0.70
2026-03-31	ABCL	3.49	-33.3	-	-0.70
2026-04-01	ABCL	3.52	-33.3	-	-0.70
2026-04-02	ABCL	3.52	-33.3	-	-0.70
2026-04-06	ABCL	3.39	-33.3	-	-0.70
2026-04-07	ABCL	3.31	-33.3	-	-0.70
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	ABCL	0.00	2.15	21.60
2026-03-10	ABCL	0.00	2.15	21.60
2026-03-11	ABCL	0.00	2.15	22.08
2026-03-12	ABCL	0.00	2.15	22.08
2026-03-13	ABCL	0.00	2.15	22.08
2026-03-17	ABCL	0.00	2.21	22.08
2026-03-18	ABCL	0.00	2.21	22.08
2026-03-19	ABCL	0.00	2.21	22.08
2026-03-20	ABCL	0.00	2.21	22.08
2026-03-23	ABCL	0.00	2.19	22.08
2026-03-24	ABCL	0.00	2.19	22.08
2026-03-25	ABCL	0.00	2.19	21.68
2026-03-26	ABCL	0.00	2.19	21.68
2026-03-27	ABCL	0.00	2.19	21.68
2026-03-30	ABCL	0.00	2.20	21.68
2026-03-31	ABCL	0.00	2.20	21.68
2026-04-01	ABCL	0.00	2.20	21.68
2026-04-02	ABCL	0.00	2.20	21.68
2026-04-06	ABCL	0.00	2.20	21.68
2026-04-07	ABCL	0.00	2.20	21.68
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ABCL 589 360 ]

Last Quarter Act. EPS

-0.03

Avg. EPS Est. Current Quarter

-0.2

Avg. EPS Est. Next Quarter

-0.2

Insider Transactions

Institutional Transactions

2.2

Beta

0.94

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.8

Max Drawdown 5-Year %

-94.4

Target Price

9.2

P/E

Forward P/E

PEG

P/S

13.32

P/B

1.03

P/Free Cash Flow

EPS

-0.49

Average EPS Est. Cur. Y

-0.7

EPS Next Y. (Est.)

-0.77

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-194.89

Relative Volume

1.01

Return on Equity vs Sector %

-42.6

Return on Equity vs Industry %

-26.1

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.01

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ABCL 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ABCL 589 450 ]

◆ ABCL Healthcare

$3.30

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

14/25

Volume

4/15

Valuation

12/20

TP/AR

2/10

Options

5/10

RSI

43.6

Range 1M

17.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

14/30

Estimates

0/20

Inst/Vol

6/15

Options

7/10

EPS Yr

-32%

EPS NY

-1.8%

52W%

30.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +178.8% upside

Quality

6/30

Valuation

16/30

Growth

8/25

Stability

7/10

LT Trend

3/5

Upside

+178.8%

Quality

AbCellera Biologics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 562

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

[News_ABCL _Stock]

stock quote shares ABCL – AbCellera Biologics Inc. Stock Price stock today

news today ABCL – AbCellera Biologics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ABCL – AbCellera Biologics Inc. yahoo finance google finance

stock history ABCL – AbCellera Biologics Inc. invest stock market

stock prices ABCL premarket after hours

ticker ABCL fair value insiders trading

ABCL – AbCellera Biologics Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABCL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y